Cleared Traditional

K950249 - VASOTRAC BLOOD PRESSURE MONITOR

K950249 is the FDA 510(k) clearance for VASOTRAC BLOOD PRESSURE MONITOR by Medwave, Inc.. It is a Class 2 Cardiovascular device (product code DXN) cleared through the Traditional 510(k) pathway after a 12-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 1995
Decision
12d
Days
Class 2
Risk

K950249 is an FDA 510(k) clearance for the VASOTRAC BLOOD PRESSURE MONITOR, MODEL - APM 205. Classified as System, Measurement, Blood-pressure, Non-invasive (product code DXN), Class II - Special Controls.

Submitted by Medwave, Inc. (St. Paul, US). The FDA issued a Cleared decision on February 1, 1995 after a review of 12 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1130 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Medwave, Inc. devices

Submission Details

510(k) Number K950249 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 20, 1995
Decision Date February 01, 1995
Days to Decision 12 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
113d faster than avg
Panel avg: 125d · This submission: 12d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DXN System, Measurement, Blood-pressure, Non-invasive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1130
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXN System, Measurement, Blood-pressure, Non-invasive

All 517
Devices cleared under the same product code (DXN) and FDA review panel - the closest regulatory comparables to K950249.
A&D UB-322 WATCH STYLE WRIST DIGITAL BLOOD PRESSURE MONITOR
K980824 · A&D Engineering, Inc. · Mar 1998
RECHARGEABLE BATTERY PART NUMBER GL825-200
K974061 · Alexander Mfg. Co. · Jan 1998
A & D UB-302 WRIST DIGITAL BLOOD PRESSURE MONITOR
K960319 · A&D Engineering, Inc. · Jul 1996
NON-INVASIVE BLOOD PRESSURE (NIBP) MONITOR (MODEL 90553)
K941167 · Spacelabs Medical, Inc. · Nov 1994
DTX AND DTX PLUS DISPOSABLE PRESSURE TRANSDUCERS AND ACCESSORIES
K935782 · Ohmeda Medical · Aug 1994
CRITIKON VITAL SIGNS MODULE
K915697 · Critikon Company, LLC · Jul 1993